Metabolic syndrome and colorectal cancer: Mechanisms, epidemiological evidence, and clinical implications

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=42

Publishing Process of This Article

Item

Count

Browse

Download

Sum=16

Dec 24, 2025 (publication date) through Dec 29, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Dec 24, 2025; 16(12): 112639
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112639

Figure 1 Mechanisms linking metabolic syndrome components to colorectal cancer. MetS: Metabolic syndrome; CRC: Colorectal cancer.

Citation: Gao F, Jiao Y, Wang HL. Metabolic syndrome and colorectal cancer: Mechanisms, epidemiological evidence, and clinical implications. World J Clin Oncol 2025; 16(12): 112639
URL: https://www.wjgnet.com/2218-4333/full/v16/i12/112639.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i12.112639